Literature DB >> 22938703

Lamellar macular hole formation in a patient with diabetic CME treated by intravitreal bevacizumab injections.

F Cuneyt Erdurman1, Alfrida Pellumbi, A Hakan Durukan.   

Abstract

A 49-year-old woman with a diagnosis of diabetic cystoid macular edema in both eyes presented with the appearance of a macular hole in the left eye 1 month after intravitreal bevacizumab injection. Optical coherence tomography demonstrated a lamellar macular hole in the left eye. Although vitreomacular traction and epiretinal membrane are the possible underlying causes for the development of lamellar macular hole formation in eyes with cystoid macular edema, in this case previous optical coherence tomography scans revealed the complete separation of the posterior hyaloid membrane and the absence of an epiretinal membrane. The exact mechanism involved in the progression of cystoid macular edema to lamellar macular hole and the contribution of the intravitreal bevacizumab injections to this transformation remain unclear. Copyright 2012, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22938703     DOI: 10.3928/15428877-20120823-05

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  4 in total

1.  Quantitative assessment of macular contraction and vitreoretinal interface alterations in diabetic macular edema treated with intravitreal anti-VEGF injections.

Authors:  Ebru Nevin Cetin; Önder Demirtaş; Nihal Cesur Özbakış; Gökhan Pekel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-20       Impact factor: 3.117

2.  Full thickness macular hole following intravitreal ranibizumab injection for diabetic macular edema; a rare complication or coincidence?

Authors:  Hasan Basri Arifoglu; Arzu Seyhan Karatepe Hashas; T Lay Ersekerci; Mustafa Atas
Journal:  Indian J Ophthalmol       Date:  2015-04       Impact factor: 1.848

3.  Lamellar macular hole formation following intravitreal bevacizumab injection for choroidal neovascularization by age-related macular degeneration.

Authors:  Hamidreza Torabi; Khosrow Jadidi; Mostafa Naderi
Journal:  Oman J Ophthalmol       Date:  2018 Sep-Dec

4.  Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema.

Authors:  Yun Wong; David H W Steel; Maged S Habib; Alex Stubbing-Moore; Dalvir Bajwa; Peter J Avery
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-12       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.